Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

Concerns have also been raised about the proportion of men who were only diagnosed after their disease had spread ...

Multidisciplinary care in prostate cancer involves urologic, radiation, and medical oncologists, optimizing treatment through a collaborative approach. Clinical trials may benefit patients with ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Combining 177 Lu-PSMA-617 with SOC produced statistically significant rPFS, reducing the risk of radiographic progression or death by 28% (HR 0.72; 95% CI, 0.58-0.90) vs SOC alone in patients with ...

Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...

Former President Joe Biden, who was diagnosed with an aggressive form of prostate cancer in May, completed a course of ...

Managing prostate cancer still begins at your doctor's office, but today we know that when it comes to treating and preventing disease, nutrition plays a role. Research confirms an association ...

Men with incurable prostate cancer are facing a “postcode lottery of care” a charity has warned after it raised concerns that ...

A week after an announcement made by Biden's office about former US President's undergoing medical care, Joe Biden rang a ...

WEDNESDAY, Oct. 22, 2025 (HealthDay News) — A powerful new drug combo has yielded a major breakthrough for men battling an ...